Bank of America Lowers UnitedHealth Group (NYSE:UNH) Price Target to $300.00

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target reduced by research analysts at Bank of America from $350.00 to $300.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a "neutral" rating on the healthcare conglomerate's stock. Bank of America's price target indicates a potential upside of 13.43% from the stock's previous close.

• Can HCA Healthcare Revive the Market’s Weakest Sector?

Several other brokerages have also recently weighed in on UNH. HSBC restated a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. KeyCorp decreased their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $389.90.

View Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

• Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound

Shares of NYSE UNH traded down $17.63 during mid-day trading on Tuesday, hitting $264.49. The company had a trading volume of 30,765,320 shares, compared to its average volume of 11,523,021. The company has a market capitalization of $239.93 billion, a price-to-earnings ratio of 11.06, a P/E/G ratio of 1.39 and a beta of 0.45. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's 50-day moving average price is $300.91 and its 200-day moving average price is $422.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm's revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.80 EPS. On average, sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

• Insiders Spent Millions on These 3 Stocks Over the Past 2 Months

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors lifted its holdings in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the period. Finally, Northern Trust Corp raised its position in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

• Five stocks we like better than UnitedHealth Group
• Growth Stocks: What They Are, What They Are Not
• Act Fast: These 3 Undervalued Stocks Won’t Stay Low for Long
• What is a Special Dividend?
• Top 220 Most Beloved Local Businesses Across the U.S. [2025 Survey]
• Insider Buying Explained: What Investors Need to Know
• Can HCA Healthcare Revive the Market’s Weakest Sector?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here